DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has launched three new employer-client contracts for its behavioral health solution powered by wayForward. According to the announcement, the contracts are for a fixed monthly fee based on the number of employees with access to the behavioral health platform; DRIP anticipates seeing revenue from these contracts by Q3 2021. The company noted that it expects additional contracts to be forthcoming in the coming months from its existing pipeline of employers as more companies recognize that Dario’s behavioral health solution addresses an unmet need. DRIO’s platform includes artificial intelligence-based screening mechanism, digital cognitive behavioral therapy modules and human coaching, which allows the company to provide care to a greater number of people at a lower average cost; in addition, the approach has been shown to significantly reduce anxiety and depression in clinical studies. “We are excited to add additional customers for Dario’s behavioral health solution and believe it continues to validate the expansion of our platform through the acquisition of wayForward,” said DarioHealth president and North America general manager Rick Anderson in the press release. “We believe that these contracts demonstrate the importance of being able to provide individual and integrated solutions while delivering significantly improved health outcomes and savings. We are also pleased to report that we have recently been selected to provide multiple solutions for several employer customers and look forward to announcing them once contracting is complete.”
To view the full press release, visit https://ibn.fm/EZZL9
About DarioHealth Corp.
DarioHealth is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market, covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Dario’s next-generation, AI-powered, digital therapeutic platform supports more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions; intuitive, clinically proven digital tools; high-quality software; and coaching to help individuals improve health and sustain meaningful outcomes. Dario’s unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results. The company’s cross-functional team operates at the intersection of life sciences, behavioral science and software technology, utilizing a performance-based approach to improve users’ health. On the path to better health, Dario makes the right thing to do the easy thing to do. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
